TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI)
CUSIP: 89680M101
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 61,418,480
- Total 13F shares
- 20,313,302
- Share change
- +9,107,663
- Total reported value
- $81,251,361
- Price per share
- $4.00
- Number of holders
- 77
- Value change
- +$32,766,003
- Number of buys
- 44
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 89680M101?
CUSIP 89680M101 identifies TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 89680M101:
Top shareholders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,250,000
mixed-class rows
|
$65,538,115 | — | 26 Jun 2023 | |
| Frankenius Equity AB |
13D/G
3/4/5
|
10%+ Owner |
14%
|
6,989,748
|
$34,179,868 | +$1,257,864 | 31 Jul 2025 | |
| First Light Asset Management, LLC |
13D/G
|
— |
8.8%
|
5,374,117
|
$22,463,809 | $0 | 31 Mar 2026 | |
| Utmost Group Plc |
13D/G
|
— |
5.7%
|
3,503,385
|
$14,644,149 | +$493,867 | 31 Mar 2026 | |
| Mats Wahlstrom |
13D/G
|
— |
6%
|
2,987,881
|
$14,610,738 | +$931,271 | 31 Jul 2025 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
4.1%
from 13D/G
|
2,070,827
|
$14,454,372 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.5%
|
1,534,336
|
$10,709,665 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
1,530,707
|
$10,684,335 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2%
|
1,243,780
|
$8,681,584 | — | 31 Dec 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.6%
|
979,023
|
$6,833,581 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
751,207
|
$5,245,335 | — | 31 Dec 2025 | |
| Wealthcare Advisory Partners LLC |
13F
|
Company |
1%
|
643,740
|
$4,493,305 | — | 31 Dec 2025 | |
| Sean Murphy |
3/4/5
|
Director |
—
mixed-class rows
|
1,308,937
mixed-class rows
|
$3,818,390 | — | 12 Jun 2025 | |
| Szela Mary T. |
3/4/5
|
CEO and President, Director |
—
mixed-class rows
|
2,331,169
mixed-class rows
|
$2,898,999 | +$45,614 | 11 Mar 2026 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.66%
|
407,500
|
$2,844,350 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.59%
|
365,255
|
$2,549,481 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
264,628
|
$1,847,103 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
222,234
|
$1,551,194 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
199,025
mixed-class rows
|
$1,383,827 | — | 31 Dec 2025 | |
| Cerity Partners LLC |
13F
|
Company |
—
class O/S missing
|
827,590
|
$1,373,799 | — | 31 Dec 2025 | |
| George Kelly Martin |
3/4/5
|
Director |
—
mixed-class rows
|
262,176
mixed-class rows
|
$1,359,468 | — | 28 Aug 2024 | |
| David Patience |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
937,556
mixed-class rows
|
$1,101,493 | +$14,994 | 23 Feb 2026 | |
| Kevin Kotler |
13F
|
Individual |
0.24%
|
145,200
|
$1,013,496 | — | 31 Dec 2025 | |
| Arjun Jj Desai |
3/4/5
|
Director |
—
mixed-class rows
|
312,127
mixed-class rows
|
$911,899 | — | 12 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
100,077
|
$698,537 | — | 31 Dec 2025 | |
| Bryan F. Cox |
3/4/5
|
Chief of Research |
—
mixed-class rows
|
425,369
mixed-class rows
|
$673,269 | -$37,763 | 11 Mar 2026 | |
| James Alecxih |
3/4/5
|
President, Device Technology |
—
class O/S missing
|
94,754
|
$521,147 | — | 10 Aug 2023 | |
| Jennifer Stevens |
3/4/5
|
Chief Regulatory Officer |
—
mixed-class rows
|
447,892
mixed-class rows
|
$511,333 | -$59,596 | 11 Mar 2026 | |
| Empire Financial Management Company, LLC |
13F
|
Company |
0.12%
|
72,027
|
$502,748 | — | 31 Dec 2025 | |
| CWA Asset Management Group, LLC |
13F
|
Company |
0.12%
|
72,000
|
$502,560 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
69,500
|
$485,110 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
65,968
|
$460,456 | — | 31 Dec 2025 | |
| Richard Marshak |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
519,334
mixed-class rows
|
$454,835 | -$48,382 | 11 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
64,604
|
$450,934 | — | 31 Dec 2025 | |
| James Emmett Young |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
154,663
mixed-class rows
|
$428,854 | — | 19 May 2025 | |
| WHITE PINE CAPITAL LLC |
13F
|
Company |
0.1%
|
58,551
|
$408,686 | — | 31 Dec 2025 | |
| Jodi Devlin |
3/4/5
|
Chief of Clinical Operations |
—
mixed-class rows
|
561,114
mixed-class rows
|
$401,139 | -$37,849 | 11 Mar 2026 | |
| Steven C. Katz |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
173,587
mixed-class rows
|
$377,229 | — | 12 Feb 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
47,699
|
$332,939 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
44,371
|
$309,710 | — | 31 Dec 2025 | |
| MSD Partners, L.P. |
13F
|
Company |
0.07%
|
39,999
|
$279,193 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.06%
|
36,550
|
$255,119 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
35,679
|
$249,039 | — | 31 Dec 2025 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
0.06%
|
34,950
|
$243,951 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
34,914
|
$243,700 | — | 31 Dec 2025 | |
| Connective Capital Management, LLC |
13F
|
Company |
0.05%
|
32,796
|
$228,916 | — | 31 Dec 2025 | |
| Magnetar Financial LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
16,668
|
$174,782 | — | 12 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
23,546
|
$164,351 | — | 31 Dec 2025 | |
| Connecticut Wealth Management, LLC |
13F
|
Company |
0.04%
|
22,303
|
$155,675 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
78,283
|
$129,167 | — | 31 Dec 2025 |
Institutional Holders of TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) as of Q1 2026
As of 31 Mar 2026,
TriSalus Life Sciences, Inc. - Common Stock, $0.01 par value (TLSI) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,313,302 shares.
The largest 10 holders included
First Light Asset Management, LLC, AWM Investment Company, Inc., Nantahala Capital Management, LLC, BlackRock, Inc., WASATCH ADVISORS LP, VANGUARD CAPITAL MANAGEMENT LLC, GILDER GAGNON HOWE & CO LLC, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, and THOMPSON SIEGEL & WALMSLEY LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
62
Q1 2026 holders
77
Holder diff
15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.